Last reviewed · How we verify

NCT06907433

Kinesiotaping and Rigid Taping in Sacroiliac Joint Dysfunction

Completed NA Last updated 2 April 2025
What this trial tests

NA trial testing Kinesiotaping in Pain in 84 participants. Completed in 1 November 2024.

Timeline
1 November 2021
Primary endpoint
1 November 2024
1 November 2024

Quick facts

Lead sponsorUfuk University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment84
Start date1 November 2021
Primary completion1 November 2024
Estimated completion1 November 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ufuk University

Who can join

Adults 18 to 50, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: To evaluate the effects of rigid-taping and kinesiotaping (lymphatic correction) on pain, joint mobility and disability in patients with sacroiliac joint dysfunction (SIJD). Methods: A total of 84 patients with unilateral SJID were included in this randomized controlled study. Patients were divided into kinesiotaping (KT) (n=28), rigid-taping (RT) (n=28) and control (n=28) groups. Pain levels at rest and during movement with visual analog scale (VAS) (0-10 cm), Oswestry Disability Index (ODI), mobility and pain provocation tests were recorded on days 1 and 15.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Kinesiotaping

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Ufuk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06907433.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing